JPH0216757B2 - - Google Patents

Info

Publication number
JPH0216757B2
JPH0216757B2 JP60245256A JP24525685A JPH0216757B2 JP H0216757 B2 JPH0216757 B2 JP H0216757B2 JP 60245256 A JP60245256 A JP 60245256A JP 24525685 A JP24525685 A JP 24525685A JP H0216757 B2 JPH0216757 B2 JP H0216757B2
Authority
JP
Japan
Prior art keywords
compound
sub
group
compounds
galactose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP60245256A
Other languages
English (en)
Japanese (ja)
Other versions
JPS61118394A (ja
Inventor
Makufuaason Yuujein
Esu Shein Fuiritsupu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JOOJITAUN UNIV
Original Assignee
JOOJITAUN UNIV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JOOJITAUN UNIV filed Critical JOOJITAUN UNIV
Publication of JPS61118394A publication Critical patent/JPS61118394A/ja
Publication of JPH0216757B2 publication Critical patent/JPH0216757B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/12—Acyclic radicals, not substituted by cyclic structures attached to a nitrogen atom of the saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)
  • Seasonings (AREA)
JP60245256A 1984-10-31 1985-10-31 ガラクトース‐ｃ‐６ナイトロジエンマスタード化合物およびその用途 Granted JPS61118394A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US666904 1984-10-31
US06/666,904 US4656159A (en) 1984-10-31 1984-10-31 Galactose-C-6 nitrogen mustard compounds and their uses

Publications (2)

Publication Number Publication Date
JPS61118394A JPS61118394A (ja) 1986-06-05
JPH0216757B2 true JPH0216757B2 (https=) 1990-04-18

Family

ID=24675999

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60245256A Granted JPS61118394A (ja) 1984-10-31 1985-10-31 ガラクトース‐ｃ‐６ナイトロジエンマスタード化合物およびその用途

Country Status (5)

Country Link
US (1) US4656159A (https=)
EP (1) EP0181154B1 (https=)
JP (1) JPS61118394A (https=)
AT (1) ATE55390T1 (https=)
DE (1) DE3579110D1 (https=)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2058070T3 (es) * 1986-05-09 1994-11-01 Pulverer Gerhard Utilizacion de monosacaridos especificos para la preparacion de un medicamento para impedir metastasis de tumores malignos.
US5126438A (en) * 1990-12-07 1992-06-30 Hawaiian Sugar Planters' Association 6,6'-dihalo-6,6'-dideoxy-1',2,3,3',4,4'-hexa-o-methylsucrose compounds
US6075134A (en) * 1997-05-15 2000-06-13 The Regents Of The University Of California Glycoconjugates and methods
CN1264616C (zh) * 2001-09-07 2006-07-19 株式会社神户制钢所 废弃化学武器中固体残渣的中和处理方法
US20050220862A1 (en) * 2004-03-31 2005-10-06 Bernstein Joel E Compositions with reduced hepatotoxicity
CA2692419C (en) * 2007-07-03 2017-12-05 Children's Hospital & Research Center At Oakland Inhibitors of polysialic acid de-n-acetylase and methods for using the same
JP5523313B2 (ja) 2007-07-03 2014-06-18 チルドレンズ ホスピタル アンド リサーチ センター アット オークランド ポリシアル酸誘導体、製造方法、ならびにがん抗原産生の増強およびターゲティングにおける使用
EP2173759A4 (en) 2007-07-03 2014-01-29 Childrens Hosp & Res Ct Oak OLIGOSIAL INSERTS, PROCESS FOR THEIR PREPARATION AND ITS IMMUNOLOGICAL USE
EP3613743B1 (en) 2008-01-04 2022-03-16 Intellikine, LLC Processes for the preparation of 1h-pyrazolo[3,4-d]pyrimidin-4-amine derivatives
US8193182B2 (en) * 2008-01-04 2012-06-05 Intellikine, Inc. Substituted isoquinolin-1(2H)-ones, and methods of use thereof
US8703778B2 (en) 2008-09-26 2014-04-22 Intellikine Llc Heterocyclic kinase inhibitors
EP2427195B1 (en) 2009-05-07 2019-05-01 Intellikine, LLC Heterocyclic compounds and uses thereof
CA2799579A1 (en) 2010-05-21 2011-11-24 Intellikine, Inc. Chemical compounds, compositions and methods for kinase modulation
JP2013545749A (ja) 2010-11-10 2013-12-26 インフィニティー ファーマシューティカルズ， インコーポレイテッド 複素環化合物及びその使用
TWI674262B (zh) 2011-01-10 2019-10-11 美商英菲尼提製藥股份有限公司 製備異喹啉酮之方法及異喹啉酮之固體形式
WO2013012915A1 (en) 2011-07-19 2013-01-24 Infinity Pharmaceuticals Inc. Heterocyclic compounds and uses thereof
MX2014000648A (es) 2011-07-19 2014-09-25 Infinity Pharmaceuticals Inc Compuestos heterociclicos y sus usos.
KR20140075693A (ko) 2011-08-29 2014-06-19 인피니티 파마슈티칼스, 인코포레이티드 헤테로사이클릭 화합물 및 그의 용도
US8940742B2 (en) 2012-04-10 2015-01-27 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
US8828998B2 (en) 2012-06-25 2014-09-09 Infinity Pharmaceuticals, Inc. Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
EP2914296B2 (en) 2012-11-01 2021-09-29 Infinity Pharmaceuticals, Inc. Treatment of cancers using pi3 kinase isoform modulators
US9481667B2 (en) 2013-03-15 2016-11-01 Infinity Pharmaceuticals, Inc. Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
WO2015051241A1 (en) 2013-10-04 2015-04-09 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
MX2021012208A (es) 2013-10-04 2023-01-19 Infinity Pharmaceuticals Inc Compuestos heterocíclicos y usos de los mismos.
NZ724368A (en) 2014-03-19 2023-07-28 Infinity Pharmaceuticals Inc Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders
WO2015160975A2 (en) 2014-04-16 2015-10-22 Infinity Pharmaceuticals, Inc. Combination therapies
WO2016054491A1 (en) 2014-10-03 2016-04-07 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
EP4585268A3 (en) 2015-09-14 2025-10-15 Twelve Therapeutics, Inc. Solid forms of isoquinolinone derivatives, process of making, compositions comprising, and methods of using the same
US10759806B2 (en) 2016-03-17 2020-09-01 Infinity Pharmaceuticals, Inc. Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitors
WO2017214269A1 (en) 2016-06-08 2017-12-14 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
RU2754507C2 (ru) 2016-06-24 2021-09-02 Инфинити Фармасьютикалз, Инк. Комбинированная терапия

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA747912A (en) * 1966-12-06 W. Hanske Willi Process for the production of deoxyribonuclease blocking agents and products obtained thereby
US2715123A (en) * 1951-11-15 1955-08-09 John E Hodge Method for conducting the amadori rearrangement of n-glycosides
BE576666A (https=) * 1958-03-14
JPS42400Y1 (https=) * 1964-04-18 1967-01-11

Also Published As

Publication number Publication date
EP0181154A2 (en) 1986-05-14
US4656159A (en) 1987-04-07
EP0181154B1 (en) 1990-08-08
DE3579110D1 (de) 1990-09-13
ATE55390T1 (de) 1990-08-15
EP0181154A3 (en) 1988-01-27
JPS61118394A (ja) 1986-06-05

Similar Documents

Publication Publication Date Title
JPH0216757B2 (https=)
RU2442789C2 (ru) Замещенные арилпиперидинилалкиниладенозины в качестве a2ar агонистов
EP1012154B1 (en) Salts of di(uridine 5'-tetraphosphate), method for preparation and uses thereof
US6503885B1 (en) Carboxymethylgalactose derivatives
US6013640A (en) Phosphoglycolipid and methods for its use
HU228937B1 (en) Compositions for treating inflammatory response
US7091334B2 (en) Method for large-scale production of di(uridine 5′)-tetraphosphate and salts thereof
IL35658A (en) 2, 6 - Diamino - 9 -) B - D - Arbinopuranosil (- Purine, its preparation and use in pharmacy
HU213208B (en) Process for preparing 3-deoxy-mannosamine derivatives and pharmaceutical compns. contg. them
US6958324B2 (en) Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease
US20140155334A1 (en) Polyphosphate and pyrophosphate derivative of saccharides
EP0181592A2 (en) Use of spergualin derivatives for the preparation of medicaments having immunosuppressive activity
WO2006023272A1 (en) 2-polycyclic propynyl adenosine analogs having a2a agonist activity
Abele et al. Phase I Clinical Study With 5'-Deoxy-5-fluorouridine, a New Fluoropyrimidine Derivative1, 2
CA1245644A (en) Galactose-c-6 nitrogen mustard compounds and their uses
WO2002076400A2 (en) Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease
US4349546A (en) D-Allose derivative and preparation method therefor
JP2004525136A5 (https=)
US20090326050A1 (en) Di(uridine 5'-)tetraphosphate and salts thereof
JP4603888B2 (ja) Ｐ−セレクチンに対する親和性を有しグルコースをベースとする化合物
JPH06503804A (ja) アニオン性フラノース誘導体、その製造法および使用法
KR820001234B1 (ko) 니트로소 우레아 화합물의 제조방법
Schein et al. 6-bis-(2-chloroethyl) amino-6-deoxy-D-galactopyranose hydrochloride: synthesis, chemical characterization, murine P388 antitumor activity, and bone marrow toxicity
JPH0136446B2 (https=)
KR20010043400A (ko) 신규 안트라사이클린 유도체 및 그 제조방법